Growth Strategies and Exit Alternatives for MedTech Companies Lessons Learned from Successful MedTech Companies Dr Richard D Gill Board Member, Launchpad.
1 Joint Academia/Industry Presentation “Changing World : Changing Pathology” Drs. Chris Zink (Johns Hopkins) and Esther Trueblood (Amgen) Co-Chairs Drs.
“Growth Strategies and Exit Alternatives for MedTech Companies”
